Shareholder Alert: Ademi LLP Investigates Whether Contextlogic Inc. (Wish) Has Obtained A Fair Price In Its Transaction With Qoo10
Date
2/13/2024 12:16:16 PM
(MENAFN- PR Newswire) MILWAUKEE, Feb. 13, 2024 /PRNewswire/ -- Ademi LLP is investigating ContextLogic (Wish) (NASDAQ: WISH )
for possible breaches of fiduciary duty and other violations of law in its transaction with Qoo10.
Click here to learn how to join the or call Guri Ademi toll-free at 866-264-3995.
There is no cost or obligation to you.
In the transaction, ContextLogic (Wish) shareholders will receive only approximately $6.50 per share at a total equity value of $173
million in cash for substantially all of its operating assets and liabilities, principally comprising its Wish ecommerce platform. The transaction agreement unreasonably limits competing transactions for ContextLogic (Wish) by imposing a significant penalty if ContextLogic (Wish) accepts a competing bid. ContextLogic (Wish) insiders will receive substantial benefits as part of change of control arrangements.
We are investigating the conduct of ContextLogic (Wish)'s board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
If you own ContextLogic (Wish) common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or .
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts
Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
SOURCE Ademi LLP
MENAFN13022024003732001241ID1107847221
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.